Meritage Portfolio Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $68.7K | Buy |
127,000
+34,500
| +37% | +$18.7K | ﹤0.01% | 317 |
|
|
2025
Q1 | $60.7K | Buy |
92,500
+7,500
| +9% | +$4.92K | ﹤0.01% | 313 |
|
|
2024
Q4 | $86.7K | Hold |
85,000
| – | – | 0.01% | 320 |
|
|
2024
Q3 | $74K | Buy |
85,000
+6,740
| +9% | +$5.87K | ﹤0.01% | 328 |
|
|
2024
Q2 | $28K | Hold |
78,260
| – | – | ﹤0.01% | 327 |
|
|
2024
Q1 | $52K | Hold |
78,260
| – | – | ﹤0.01% | 335 |
|
|
2023
Q4 | $43K | Hold |
78,260
| – | – | ﹤0.01% | 330 |
|
|
2023
Q3 | $47K | Hold |
78,260
| – | – | ﹤0.01% | 323 |
|
|
2023
Q2 | $102K | Hold |
78,260
| – | – | 0.01% | 335 |
|
|
2023
Q1 | $138K | Hold |
78,260
| – | – | 0.01% | 307 |
|
|
2022
Q4 | $246K | Hold |
78,260
| – | – | 0.02% | 281 |
|
|
2022
Q3 | $383K | Buy |
+78,260
| New | +$383K | 0.03% | 229 |
|